XML 61 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Components of Share-Based Compensation Expense by Type of Award The following table lists the components of share-based compensation expense by type of award.
 Years Ended December 31,
 202420232022
Restricted stock$2,119 $2,237 $3,635 
Performance share units1,021 570 602 
Stock options— 14 140 
Share-based compensation expense$3,140 $2,821 $4,377 
Reconciliation of Restricted Stock Option Activity
The following table presents the status of unvested restricted stock awards as of December 31, 2024 and changes during the year then ended.
Nonvested
Restricted
Shares		Weighted Average Grant-Date
Fair Value
Unvested at January 1, 20243,405 $1.41 
Granted660 4.25 
Vested(1,480)1.33 
Forfeited(259)2.13 
Unvested at December 31, 20242,326 $2.18 
During the year ended December 31, 2024, we granted 390,000 shares of restricted stock to non-executive directors, officers and certain other employees which vest pro-rata over three years for employees and over one year for non-executive directors. In addition, we granted 270,000 shares of restricted stock to new executive officers as inducement grants, during the year ended December 31, 2024, which vest pro-rata over five years.
Summary of Status of Unvested PSU Awards
The following table presents the status of unvested PSUs as of December 31, 2024 and activity during the year then ended.
 Nonvested PSU AwardsWeighted Average Grant-Date
Fair Value
Nonvested at January 1, 20243,789 $1.29 
Granted590 3.71 
Vested(12)2.53 
Forfeited(427)2.40 
Expired(269)2.58 
Nonvested at December 31, 20243,671 $1.45 
Schedule of Stock Options Roll Forward The following table presents stock option activity for the year ended December 31, 2024.
Number of OptionsWeighted-Average
Exercise Price		Weighted-Average Remaining Contractual TermAggregate
Intrinsic
Value		 
Outstanding at January 1, 2024296 $14.46 
Expired(127)15.07 
Outstanding and exercisable at December 31, 2024169 $13.99 2.6 years$— (1)
_______________________________
(1)The aggregate intrinsic value is the sum of intrinsic values for each exercisable individual option grant. The intrinsic value is the amount by which the closing market price of our stock at December 31, 2024, was greater than the exercise price of any individual option grant